Theranos Inc. received much of its funding from high-profile private investors who weren’t part of the ecosystem that typically backs startups and could see their stakes wiped out by the blood-testing company’s regulatory and technological troubles…
The Best in Alternative News
at
Theranos Inc. received much of its funding from high-profile private investors who weren’t part of the ecosystem that typically backs startups and could see their stakes wiped out by the blood-testing company’s regulatory and technological troubles…
Any publication posted at The T-Room and/or opinions expressed therein do not necessarily reflect the views of The T-Room. Such publications and all information within the publications (e.g. titles, dates, statistics, conclusions, sources, opinions, etc) are solely the responsibility of the author of the article, not The T-Room.